Search

Home > News > Current news

Current news

RCIPS current news

National innovation award for UCT engineer’s urine project
Tue, 06 Jul 2021 - 13:45

The University of Cape Town’s (UCT) Associate Professor Dyllon Randall has won the South African Institution of Chemical Engineers (SAIChE) 2021 Innovation Award for a project on the development of a fertiliser-producing urinal and urine bio-brick process.

 
European Patent Granted for HIV Prevention Point-of-Care Test - “GIFT”.
Mon, 07 Jun 2021 - 13:00

A European Patent was recently granted to UCT by the European Patent Office (EPO) for a Method for Diagnosing an Inflammatory Condition in the Female Genital Tract invented by Dr Lindi Masson and A/Prof Jo-Ann Passmore.

Creating UCT Spin-Off Companies – Guide Launched
Mon, 10 May 2021 - 12:45

As new Guide to Creating a University Spin-off Venture was launched as part of UCT’s 2021 World Intellectual Property Day celebrations which have the theme: IP and SMEs: Taking your Ideas to Market.

The importance of industry-academia collaboration
Wed, 24 Feb 2021 - 15:00

The University of Cape Town's Research Contracts & Innovation (RC&I) department strives to enable industry engagement & research funding contracts for UCT researchers, inventors & innovators.

Lumkani scoops R20m in the EU’s EIC Horizon Prize
Thu, 08 Oct 2020 - 14:15

Lumkani, a University of Cape Town (UCT) spin-off company, with the mission to mitigate the loss of life and property caused by shack fires in South Africa and across the world, has won R20-million the EU’s EIC Horizon Prize.

New multi-functional TB blood test validated
Wed, 03 Jun 2020 - 13:15

Researchers from the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT), the Center for Global Infectious Disease Research – Seattle in the United States, and a large consortium of collaborators have developed a validated a new, simple blood-based test that has the potential to serve multiple functions in the fight against TB.

Harnessing plant power to curb COVID-19
Fri, 29 May 2020 - 12:00

Here’s a different reason for tobacco to be in the news. Cape Bio Pharms, a biotech company with its origins in the Biopharming Research Unit (BRU) at the University of Cape Town (UCT), has joined the global effort to create a fast and affordable antibody test for COVID-19, using a relative of the tobacco plant.

Production of safe, affordable bottle spacers ramped up
Mon, 18 May 2020 - 12:30

UCT alumni have designed a rig to increase production of the bottle spacers that administer metred medication dosages to patients

Developing a vaccine for COVID-19
Wed, 22 Apr 2020 - 10:00

As COVID-19 infection and morbidity rates increase around the globe, a number of companies and academic institutions have entered the race to develop a vaccine to protect us from the lethal virus. Creating a vaccine is, however, a complex process and could take several months, if not years.

RC&I Operations During COVID-19 Shut Down
Fri, 27 Mar 2020 - 14:15

The South African national shutdown commenced on 27 March 2020 and will continue for 21 days.  During this period RC&I staff will be working remotely and essentially all functions will be operating as normal. 

UCT participates in Africa’s first University Technology Fund
Thu, 27 Feb 2020 - 16:00

The SA SME Fund recently launched the University Technology Fund (UTF), a first of its kind in Africa. The University of Cape Town (UCT) and Stellenbosch University are the first two universities that will participate in the fund, which will provide UCT spin-off companies with access to R50 million, as well as additional seed funding to support innovation projects within the university.

UCT Innovation Builder off to a flying start
Wed, 29 Jan 2020 - 10:15

UCT launched the Innovation Builder Fund (IBF) in 2019 with the inaugural call for applications in the second semester. The IBF aims to fund projects to further develop and test preliminary research outputs from UCT where initial proof of concept has been demonstrated using research funding with the goal of increase the commercialisation of UCT technologies, or to better position them for next-round innovation funding. Funding of up to R500 000 per project is considered.

Pages